COVID-19 as an infectome paradigm of autoimmunity

J Allergy Clin Immunol. 2022 Jan;149(1):63-64. doi: 10.1016/j.jaci.2021.11.009. Epub 2021 Nov 24.

¹ Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
² Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medicine "B", Sheba Medical Center, Ramat Gan, Israel.
³ Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
⁴ Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Ariel University, Ari'el, Israel; Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint Petersburg, Russia. Electronic address: Yehuda.Shoenfeld@sheba.health.gov.il.

No abstract available

Keywords: COVID-19; Microbiome; autoimmunity; infectome; lung microbiome.

Publication types